|
Glenza A., Elmi S., Yakushin S.S., Pereverzeva K.G., Dobrynina N.V.
Risk factors and 6-year prognosis in the continuum of arterial hypertension development among the population of Ryazan region
|
№10 / 2024
|
|
Usanova A.A., Novikova E.K., Sergutova N.P., Kuzma F.M., Vasilkova A.S.
New horizons in managing dyslipidemia – a risk factor for cardiovascular diseases
|
№9 / 2024
|
|
Kucherova N.Yu., Tsyganova Yu.V., Tarasova L.V.
Peculiarities of lipid metabolism and vascular wall rigidity in ulcerative colitis patients
|
№3 / 2024
|
|
Skuridina D.V., Demidova T.Yu.
Clinical and metabolic peculiarities in male patients with type 2 diabetes mellitus and hypogonadism
|
№9 / 2023
|
|
Prekina V.I., Kunyaeva T.A., Shokina S.V., Samolvina O.G., Skopina Yu.A.
Correction of risk factors in patients with atrial fibrillation
|
№8 / 2023
|
|
Larina V.N., Fedorova E.V., Sayno O.V., Mironova T.N., Orlov D.A.
The incidence of abdominal obesity and its association with risk factors for cardiovascular disease in middle-aged people
|
№8 / 2022
|
|
Boeva O.I., Kokorin V.A.
Alirocumab in patients of very high cardiovascular risk
|
№1 / 2022
|
|
I.I. Shaposhnik, I.I. Reznik
The use of statines in outpatient practice in high and very highrisk patients
|
№5 / 2017
|
|
N.T. Vatutin, A.S. Smirnova, Ye.S. Gasendich
The evaluation of lipid profile in patients with chronic heart failure and concomitant chronic obstructive pulmonary disease
|
№6 / 2016
|
|
A.R. Volkova, S.V. Dora, O.A. Berkovich, O.D. Dygun, Ye.V. Volkova, Ye.N. Ostroukhova
Subclinical hypothyroidism – new cardiovascular risk factor
|
№6 / 2016
|
|
V.А. Shevtsova, A.L. Vertkin
Experience with the use of meldonium in long immobilized patients with cerebrovascular diseases
|
№1 / 2015
|
Русский
